|Home | About | Journals | Submit | Contact Us | Français|
The European level of alcohol consumption, and the subsequent burden of disease, is high compared to the rest of the world. While screening and brief interventions in primary healthcare are cost-effective, in most countries they have hardly been implemented in routine primary healthcare. In this study, we aim to examine the effectiveness and efficiency of three implementation interventions that have been chosen to address key barriers for improvement: training and support to address lack of knowledge and motivation in healthcare providers; financial reimbursement to compensate the time investment; and internet-based counselling to reduce workload for primary care providers.
In a cluster randomized factorial trial, data from Catalan, English, Netherlands, Polish, and Swedish primary healthcare units will be collected on screening and brief advice rates for hazardous and harmful alcohol consumption. The three implementation strategies will be provided separately and in combination in a total of seven intervention groups and compared with a treatment as usual control group. Screening and brief intervention activities will be measured at baseline, during 12 weeks and after six months. Process measures include health professionals’ role security and therapeutic commitment of the participating providers (SAAPPQ questionnaire). A total of 120 primary healthcare units will be included, equally distributed over the five countries. Both intention to treat and per protocol analyses are planned to determine intervention effectiveness, using random coefficient regression modelling.
Effective interventions to implement screening and brief interventions for hazardous alcohol use are urgently required. This international multi-centre trial will provide evidence to guide decision makers.
ClinicalTrials.gov. Trial identifier: NCT01501552
The European Union (EU) has the highest alcohol consumption of the world: in 2009, the average adult (aged 15+ years) alcohol consumption in the EU was 12.5 litres of pure alcohol . A review showed that consumption above 20 to 30 grams of alcohol a day (two to three glasses of wine) increases an individual’s risks of mortality and morbidity [2,3]. However, people often overestimate the positive health effects of alcohol; in fact, only small amounts of alcohol have positive effects on health [2,3].
Alcohol consumption is the third world leading cause of diseases and premature death . The costs related to alcohol are €125bn a year for health, welfare, employment, and criminal justice sectors as a consequence of alcohol-attributable disease, injury, and violence . Therefore, individuals and society would benefit from effective preventive measures with respect to morbidity and mortality and social costs.
There is considerable evidence showing that early identification of hazardous and harmful alcohol consumption result in reduced alcohol consumption and improved health outcomes. Primary healthcare (PHC) is the primary point of contact for many people seeking healthcare. In this setting, screening  and brief intervention programs have proven to be effective in reducing alcohol consumption [6-10], with a mean reduction of 38 grams of alcohol per week (three to four glasses of wine) . Although the evidence is still inconsistent about positive effects of nurse-led interventions [11,12], generally screening and brief interventions are provided by healthcare workers such as GPs, nurses, or psychologists . The number needed to treat (NNT) in offering screening and brief interventions is eight (for every eight people treated one will change their behaviour) , which is relatively low compared to smoking cessation, which has a NNT of around 35 or higher . Despite the evidence for efficacy and cost-efficacy of screening and brief interventions in PHC, these interventions are rarely implemented in routine practice . Commonly, less than 10% of the population at risk are identified, and less than 5% of those who could benefit are offered screening and brief interventions in PHC settings .
Some of the reasons for this gap are identified and can be categorised in three main domains. First, evidence suggests there is substantial lack of knowledge among general practitioners (GPs) [5,16]. A survey across 13 countries found that one-third of all GPs reported never receiving alcohol-related education, 23% reported less than four hours, and 37% reported more than seven hours of alcohol-related education ever . A recent update from England has shown that 52% of the United Kingdom’s surveyed GPs indicated that they had received less than four hours of post-graduate training, continuing medical education, or clinical supervision on alcohol and alcohol related problems . Furthermore a lack of role security and therapeutic commitment has been identified .
Secondly, lack of adequate resources and support are identified as important barriers [16,20]. Financial reimbursement could be important measures to overcome this barrier, but as far as we know, there have been no randomised controlled trials conducted investigating the impact of reimbursement for alcohol screening and brief interventions in the PHC setting.
The third important barrier relates to time constrains in terms of perceived workload and work pressure for screening and brief intervention activities . In PHC, trained nurses are increasingly involved in preventive care activities and in the management of chronic ill patients due to the increased workload of GPs. It has shown that they provide safe and effective care . This study focuses on all healthcare professionals working at primary healthcare units (PHCUs).
Although previous implementation studies [22,23] have tried to increase screening and brief interventions in primary healthcare, the gap between scientific knowledge and everyday clinical practice remains . With regard to the first category of barriers of knowledge and attitude, earlier studies found that training and support could make GPs even less secure in their work with drinkers, when the training and support does not address prior GP’s attitude in the training and support [15,19]. In the ODHIN study, we will tailor our implementation strategy to the primary healthcare worker’s prior attitude. With regard to the second category, lack of resources, there are mixed results of evidence of finance systems to change provider behaviour [25,26]. There is limited evidence that finance systems can change provider behaviour of screening and brief interventions of alcohol . Still, financial incentives for smoking cessation interventions have shown a significant positive outcome on increases in referral to tobacco cessation services , and suggest financial support for alcohol interventions might be effective. In the third category, workload and work pressure, we suggest e-health interventions might be of benefit. E-self help interventions without therapist support are available both in brief and more extended formats and have shown to be effective in reduction of alcohol consumption . Additionally, internet interventions with therapist support focused on depression and anxiety were found to have larger effect sizes compared to internet interventions without therapist support , but has not yet been tested for alcohol internet interventions. These e-health interventions might be helpful to reduce workload of healthcare professionals after identification of patients at risk as well as availability for patients 24 h a day. Therefore, it is of interest to test if primary healthcare workers’ referral to internet-based brief interventions, hereafter termed e-BI, could be time-saving for healthcare professionals and consequently might raise primary care worker’s intervention activity.
It is of significant public health interest to explore, and optimize, effective implementation strategies to improve PHC activities in screening and brief interventions for hazardous and harmful alcohol consumption. In the current study, we evaluate the effect of three strategies, each aimed to tackle one of the above reported barriers, singly or in combination, in order to overcome the gap between knowledge and daily practice.
Our aim is to study the effectiveness of training and support (T&S), financial reimbursement, and internet based brief interventions (e-BI), targeted singly or in combination to primary healthcare units, on screening and brief intervention activities, compared to treatment as usual. The following hypotheses will be tested in the study:
1. Provision of training and support to primary healthcare providers will increase use of preventive screening and brief interventions compared to a care as usual control group.
2. Financial reimbursement to primary healthcare providers as a pay-for-performance of brief alcohol interventions will increase screening and brief intervention rates compared to care as usual.
3. Providing resources, i.e., offering referral possibility to an internet-based method of delivering brief intervention, will increase screening and brief intervention rates compared to care as usual.
4. The combination of training and support, financial reimbursement, and e-BI will be more effective in increasing screening and brief intervention rates compared to single-focused implementation strategies.
Our study is designed as a cluster randomized factorial trial. Data from PHCUs in Catalonia, England, the Netherlands, Poland, and Sweden will be combined to examine the effect of three different implementation strategies singly or in combination on screening and brief advice rates for hazardous and harmful alcohol consumption compared with care as usual (controls). In all countries, the complete trial will be conducted between August 2012 and December 2013.
PHCUs with approximately 5,000 to 20,000 registered patients will be the unit of randomization and implementation. In Poland, because practitioners normally operate as single-handed entities working with other practitioners in one building, three practitioners and their staff working in one building will be the unit of randomization. PHCUs who agree to participate in the study are volunteers that will be drawn from administrative or academic registries of PHCU at national or regional levels. PHCUs that have current ongoing alcohol-related projects that have a focus on screening and brief interventions, involve GPs and/or nurses, and include one of the ODHIN implementation strategies, will be excluded.
Besides fully-trained GPs, nurses or practice assistants with a permanent appointment working in the PHCU and involved in medical and/or preventive care are also eligible, because they also have skills to assist in screening and brief interventions [12,30,31]. At the start of the study, all eligible providers within the PHCU will be identified by the research team. Participating providers are those eligible providers who agree to participate in the trial. Before baseline measurement, the participating providers have to sign up for the study, allowing PHCU with a high number of staff to include only a selection of staff. Staff not able to attend this meeting but willing to participate will be informed by the contact person in the PHCU. These providers will also sign an informed consent for their participation. In the Netherlands, England, Poland and Sweden, PHCU will receive a trial fee. The trial flow chart is shown in Figure1.
The implementation period will last twelve weeks, with the start date for each country between November 2012 and March 2013. The start date of the implementation period for each PHCU will be staggered. Implementation strategies are outlined in detail in Table1. All groups will receive the same input as controls but with additional components added. These strategies are about to be tested singly or in combination:
1. Control group, treatment as usual
3. Financial reimbursement
5. T&S and financial reimbursement
6. T&S and e-BI
7. Financial reimbursement and e-BI
8. T&S, financial reimbursement, and e-BI
A graphical depiction of the study is depicted in Additional file 1.
An introductory meeting (first briefing) will be held in all PHCUs that agree to participate in the study, describing the study’s purpose and the four-week baseline data collection, which will follow the introductory meeting. After the baseline data collection, all PHCUs will receive a second briefing within one month, either face to face or by telephone, tailor-made to the study group to which they are allocated.
PHCUs will be asked to screen all patients aged 18 years and over who attended the PHCU. These patients are defined as eligible patients.
Patients will be screened for hazardous and harmful alcohol consumption with AUDIT-C . Screen positives, or at risk patients, are defined as those who scored ≥ 5 for men or ≥ 4 for women on AUDIT-C. Participating staff that have signed up to the study will be asked to deliver brief alcohol advice of 5 to 15 min duration to at-risk patients, with the length and format of the brief advice based on country-specific guidelines or, for Poland where national guidelines are lacking, the European guidelines developed by PHEPA . Providers of PHCUs allocated to e-BI activity will be asked to refer patients to a computerized brief advice program, considered equivalent to providing brief advice. Besides counting referral rate to e-BI, actual e-BI log-in rates of patients will be collected.
Screening and brief advice will be measured at five timepoints: during the four-week baseline period, the three consecutive four-week blocks during the twelve week implementation period; and, the four-week follow-up period, which will occur during the seventh month after the end of the twelve-week implementation period using paper tally sheets, with the exception of Catalonia who will use their electronic patient records. The tally sheets include AUDIT-C scores (i.e., identification of at risk patients) with additional table to indicate the type of brief advice that was delivered to the patients at risk. Gender and age of patients will be recorded as well as the name and profession of the provider.
The screening rate will be calculated as the number of completed screens divided by the total number of consultations of all patients eligible for screening (as defined above) per participating provider times 100. The brief advice rate will be calculated as the number of BIs delivered (received oral brief advice, and/or were given an advice leaflet, and/or were referred to the e-BI program, and/or were referred to another provider in or outside the practice), divided by the total number of screen positives per participating provider times 100. Information will also be collected on the number of screen negatives who received brief advice.
Screening and brief advice rates will be calculated at two levels: at an aggregate PHCU level for all participating providers in the PHCU; and, at an individual provider level for each participating and actively participating providers. Participating providers are defined as those who attended the first briefing, or who were identified as joining the study by the contact person of the PHCU at the first briefing. Actively participating providers are defined as those participating providers who completed at least one tally sheet or computerized record during one of the measurement periods.
Role security and therapeutic commitment of the participating providers will be measured by the short version of the Alcohol and Alcohol Problems Perception questionnaire (SAAPPQ)  at three time points: at or immediately after the first introduction meeting, at the end of the 12-week implementation period, and during the end of the four-week follow-up period. All participating providers who have signed an informed consent will be asked to complete the SAAPPQ at each of the three time points. The responses will be summed within the two scales of role security and therapeutic commitment. Individual missing values for any of the items in a domain will be assigned the mean value of the remaining items of the domain before summation.
Randomization will take place after formal agreement of the PHCU to take part in the trial. The PHCU will be randomly allocated to one of eight groups by the European coordinating centre, using computerized randomization stratifying by country, ensuring 15 PHCUs per group (three per country). Although the PHCUs will be randomly allocated before the baseline measurement, the research team in each of the countries and the PHCU only are informed of the allocation after collection of the baseline measurement to avoid bias as a result of group allocation. For the remainder of the study period, the PHCU and investigators will not be blind to group allocation.
It is estimated that 56 PHCUs (seven per eight allocation groups) with a minimum of 1,000 eligible patients per month would be needed for a 80% chance of detecting an increase in screening rates from 8% to 12% (ICC = 0.029) and that 120 PHCUs (15 per eight allocation groups) would be needed for a 80% chance of detecting an increase in brief advice rates from 4% to 6% (ICC = 0.029) (alpha = 5%). As country is used as stratification criteria each country has to include a minimum of 24 PHCUs. These conservative estimates are based on published evidence of screening and advice rates [22,23].
Because of the hierarchical structure of the data (individual providers nested within PHCU nested within country), we will perform multilevel analyses of the screening and advice rates to examine the effect of the implementation strategies in comparison with the controls. The intention to treat analyses will include all participating providers (see above). Per protocol analyses will include only actively participating providers (see above). In all the analyses, we will use exposure to the implementation strategy as co-variate. Exposure is defined as positive if the providers meet the following criteria: financial—the PHCU received the financial reimbursement; e-BI—the provider handed out at least one referral card; and T&S—the provider attended the two face-to-face educational meetings. If these criteria will not be met, the exposure will be defined as negative.
Analyses will be performed in SAS V9.2 and based on mixed effects model (PROC GLIMMIX and PROC MIXED). We will use a random intercept model with fixed variables.
By conducting this trial, we are trying to address the well-known implementation gap (evidence to practice) of screening and brief interventions for hazardous and harmful alcohol consumption in PHC. For example, researchers rarely have been in a position to actively compare a number of incentive-based strategies. With this trial, we aim to assist in building a knowledge base, on which policy could be based on.
We are aware of some strengths and limitations of this trial. This trial is approached pragmatically. In other words, each of the five countries differs slightly in the implementation strategy contents. For example, countries will differ in their distribution of research fees, amount of financial reimbursements, and deliverers of training and support strategies. The research team explicitly determined this pragmatic approach, because they considered this approach being most valuable for country policy makers. Albeit, in terms of research, this is less powerful because there are small variations in implementation strategies per country.
The five participating countries are different in their organization of primary care and have different drinking patterns. This creates opportunities to conduct across-country analyses and relate different implementation rate outcomes to cultural and organizational differences. These results can consequently be applicable through Europe and other similar Western countries. In the future, if our implementation strategies result in improved screening and brief intervention rates, other countries with comparable primary care systems could use these strategies to improve the prevention of hazardous and harmful alcohol consumption in their country.
e-BI: Internet based brief interventions; PHC: Primary healthcare; PHCU: Primary healthcare unit; SAAPPQ: Short Alcohol and Alcohol Perceptions Questionnaire; T&S: Training and support.
The authors declare that they have no competing interests.
MK, PA, and ML wrote the first draft of the manuscript and all other authors revised the manuscript critically. PB, FS, and PA were responsible for the original set up of the study design, which has further been discussed with all authors during three meetings. The final and in this paper presented design is the outcome of these discussions and written comments of all authors. All authors read and approved the final manuscript.
Graphical depiction of ODHIN study. This image graphically describes the way ODHIN is designed. It makes a distinction between procedure activities, measures and implementation strategies. It also gives an insight of time schedule of depicted activities.
The research leading to these results or outcomes has received funding from the European Community’s Seventh Framework Program (FP7/2007-2013), under Grant Agreement nº 259268 – Optimizing delivery of healthcare intervention (ODHIN). Participant organisations in ODHIN can be seen at: http://www.odhinproject.eu.
Radboud University Nijmegen Medical Centre received co-funding from The Netherlands Organisation for Health Research and Development (ZonMW, Prevention Program), under Grant Agreement nº 200310017 – ODHIN – Optimizing delivery of healthcare interventions in the Netherlands, according Art.II.17 of the FP7 EC Grant Agreement.
The following individuals were part of the WP5 ODHIN group, besides the authors of this study protocol: Begoña Baena (Spain), Amy Wolstenholme (UK) , Marcin Wojnar (Poland), Katarzyna Okulicz- Kozaryn (Poland), Krzysztof Brzózka (Poland), Luiza Slodownik (Poland), Gaby Ronda (Netherlands), Trudy van der Weijden (Netherlands), Michel Wensing (Netherlands).